Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. Baskett
Observed name:
A Baskett
Institution:
Ipsos (United Kingdom)
Observed institution:
Ipsos (United Kingdom)
OpenAlex ID:
A5108790900
Php113 - Comparative Analysis of Biosimilar Rituximab Usage in Treating Non-hodgkin Lymphoma and Rheumatoid Arthritis: Results From a Multi-country Study in Europe
2018
·
A. Franceschetti
, A. Baskett
, et al.
·
Value in Health
·
3
Perceptions of Biosimilars Across Physician Specialities in Europe
2018
·
B Shah-Manek
, A Baskett
, et al.
·
Value in Health
·
3
PDF
Perceptions of Cost Pressure Associated with Biosimilars Among Physicians in Europe
2018
·
C Karki
, A Baskett
, et al.
·
Value in Health
·
2
Prs3 Comparison of Disease Burden Between Severe Asthma Patients Perceived by Their Physician as Highly Adherent to Their Biologic Therapy Versus Those Not Perceived as Highly Adherent
2020
·
S. Brown
, A. Baskett
, et al.
·
Value in Health
Comparative Impact on Days Missed from Work Between Biologic Versus Non-Biologic Moderate-to-Severe Asthma Patients
2020
·
V. Allan
, S. Brown
, et al.
·
American Journal of Respiratory and Critical Care Medicine
THU0644 Perceptions of biosimilars among practicing rheumatologists: results from a multicountry study in europe
2018
·
C. Karki
, S. Shah
, et al.
·
Annals of the Rheumatic Diseases
PDF
P774 Comparison of disease burden of ulcerative colitis patients treated with biologics/biosimilars in remission and not in remission across the EU5
2018
·
Y Lu
, A Baskett
, et al.
·
Journal of Crohn s and Colitis
AB0316 Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Treated with Biologic theRapies in Japan
2015
·
S. Narayanan
, Y. Lu
, et al.
·
Annals of the Rheumatic Diseases
FRI0054 Comparison of Patients with Rheumatoid Arthritis on Disease Remission in Europe and United States
2015
·
S. Narayanan
, Y. Lu
, et al.
·
Annals of the Rheumatic Diseases
AB1189 Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Identified by Physicians as Potentially Suitable for Biosimilar Infliximab Versus those Who were not Considered Biosimilar Infliximab Suitable in Europe
2015
·
Y. Lu
, S. Narayanan
, et al.
·
Annals of the Rheumatic Diseases
Comparison of Clinical Characteristics of Patients With Rheumatoid Arthritis (RA) Identified By Physicians As Potentially Suitable For Biosimilar Infliximab Versus Those Who Were Not Considered Biosimilar Infliximab Suitable In Europe (EU)
2015
·
S. Narayanan
, Y. Lu
, et al.
·
Value in Health
PDF
Patterns of Disease Remission Among Patients With Rheumatoid Arthritis Treated With Biologic Therapies In Japan
2015
·
S. Narayanan
, Y. Lu
, et al.
·
Value in Health
Relationship Between Physician Assessment of Disease Severity (Per Clinical Judgment) and Objective Measures of Disease Severity In Rheumatoid Arthritis (RA): Observations From The European Union (EU) And United States (US)
2015
·
S. Narayanan
, Y. Lu
, et al.
·
Value in Health
Comparison of Patients With Rheumatoid Arthritis (RA) On Disease Remission In The European Union (EU) And United States (US)
2015
·
S. Narayanan
, Y. Lu
, et al.
·
Value in Health
FRI0275 Impact of Disease Severity on Duration of Use of First Biologic among Patients with Rheumatoid Arthritis in Uk, Germany, France, Italy and Spain
2014
·
S. Narayanan
, Y. Lu
, et al.
·
Annals of the Rheumatic Diseases
THU0189 Patterns of Disease Remission among Patients with Rheumatoid Arthritis Treated with Biologic Therapies in the United States
2014
·
S. Narayanan
, Y. Lu
, et al.
·
Annals of the Rheumatic Diseases
Patterns Of Disease Remission Among Patients With Rheumatoid Arthritis Treated With Biologic Therapies In The United States
2014
·
S. Narayanan
, Y. Lu
, et al.
·
Value in Health
Impact Of Disease Severity On Duration Of Use Of First Biologic Among Patients With Rheumatoid Arthritis (Ra) In Uk, Germany, France, Italy And Spain (5eu)
2014
·
S. Narayanan
, Y. Lu
, et al.
·
Value in Health
Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic and Biologic-Naïve Patients Considered Biologic-Suitable in the United States
2013
·
S. Narayanan
, A. Baskett
, et al.
·
Value in Health
Comparison of Disease Status, Treatments and Outcomes of Patients with Psoriatic Arthritis Receiving Their First Biologic in the European Union and United States
2013
·
S. Narayanan
, A. Baskett
, et al.
·
Value in Health
PDF
Disease Status, Treatments and Outcomes of Patients with Ankylosing Spondylitis Receiving Their First Biologic in the United States and European Union
2013
·
S. Narayanan
, A. Baskett
, et al.
·
Value in Health
Patient Eligibility and Use of Biologics in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis in the United States
2013
·
S. Narayanan
, A. Baskett
, et al.
·
Value in Health
PDF
Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic in Europe Union and the United States
2013
·
S. Narayanan
, A. Baskett
, et al.
·
Value in Health
Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Receiving Their First Biologic in European Union
2013
·
S. Narayanan
, A. Baskett
, et al.
·
Value in Health
PDF
Disease Burden Among Patients with Psoriatic Arthritis Who Have Experienced First Line Tumor Necrosis Factor Inhibitor Regimen Failure in the European Union
2013
·
S. Narayanan
, Y. Lu
, et al.
·
Value in Health
Show more works
View as search
Works count:
30
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type
